-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS ANNOUNCES COMMERCIAL LAUNCH OF IMCIVREE® (SETMELANOTIDE) IN JAPAN FOR PATIENTS WITH ACQUIRED HYPOTHALAMIC OBESITY

Reuters·10/13/2026 23:30:00

Please log in to view news